Genetic Testing Registry (OD)

ICR 201111-0925-007

OMB: 0925-0651

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Supplementary Document
2012-02-29
Supplementary Document
2012-02-29
Supplementary Document
2011-11-18
Supplementary Document
2011-11-18
Supporting Statement A
2012-02-29
IC Document Collections
IC ID
Document
Title
Status
200267 New
ICR Details
0925-0651 201111-0925-007
Historical Active
HHS/NIH
Genetic Testing Registry (OD)
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 02/29/2012
Retrieve Notice of Action (NOA) 11/28/2011
This collection is approved contingent on a commitment by NIH to develop and test a more active community policing mechanism or NIH moderator role within the next 18 months. The plan and pilot test design should be submitted to OMB as a non-substantive change to the current approval.
  Inventory as of this Action Requested Previously Approved
02/28/2015 36 Months From Approved
9,240 0 0
27,720 0 0
0 0 0

In 2010, NIH announced its plan to develop the Genetic Testing Registry (GTR), a centralized, online resource that will provide information about the availability and scientific basis of genetic tests. With an increasing number of genetic tests available, NIH recognized the importance of making information about these tests easily accessible to health care providers, researchers, patients, consumers, payers, and others. The overarching goal of the GTR is to advance the public health and research in the genetic basis of health and disease. As such, the Registry will have several key functions, including (1) encouraging providers of genetic tests to enhance transparency by publicly sharing information about the availability and utility of their tests; (2) providing an information resource for the public, including health care providers, patients, and researchers, to locate laboratories that offer particular tests; and (3) facilitating genetic and genomic data-sharing for research and new scientific discoveries. The GTR will be created, designed, and maintained by the NIH National Center for Biotechnology Information (NCBI) with input from the stakeholder community and oversight by an NIH steering group. Respondents to the GTR are expected to include clinical laboratories, test manufacturers, researchers, and entities that report and interpret tests performed elsewhere. The GTR is not limited to U.S. respondents; it will also include submissions from outside the United States. Information will be collected and managed using an online submission system.

US Code: 42 USC 46 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  76 FR 44937 07/27/2011
76 FR 72424 11/23/2011
Yes

1
IC Title Form No. Form Name
Laboratory Personnel 1 Registry

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 9,240 0 0 9,240 0 0
Annual Time Burden (Hours) 27,720 0 0 27,720 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new ICR.

$2,900,000
No
No
No
No
No
Uncollected
Seleda Perryman 202 690-5521

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/28/2011


© 2024 OMB.report | Privacy Policy